Form 4 for CVS CVS Health
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001127602-22-011633 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-05 | 2022-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $101.09 | -116.9K | 210.1K | -36% | -$11.82M |
| D | 2022-04-05 | 2022-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $101.09 | +171.5K | 171.5K | New | +$17.34M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | F | D | 116,940 | $101.09 | 210,090 | D | — | — | (F1) Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022. |
| 2 | Derivative | Stock Option | 2022-04-01 | A | A | 171,517 | $101.09 | 171,517 | D | $101.09 · 2023-04-01 to 2032-04-01 | 171,517 Common Stock | (F2) Option becomes exercisable in four equal installments, commencing 4/1/2023. |